In vitro formation of amyloid fibrils from two synthetic peptides of different lengths homologous to Alzheimer's disease beta-protein - PubMed (original) (raw)

In vitro formation of amyloid fibrils from two synthetic peptides of different lengths homologous to Alzheimer's disease beta-protein

E M Castaño et al. Biochem Biophys Res Commun. 1986.

Free article

Abstract

Two synthetic peptides corresponding to the reported 28-residue sequence of Alzheimer's Disease beta-protein (SP28) and to residues 12-28 (SP17) were used to form fibrils in vitro. Synthetic fibrils bound Congo Red and closely resembled amyloid fibrils isolated from leptomeninges and senile plaques of Alzheimer's brain by electron microscopy. A polyclonal antiserum to SP28 specifically decorated both synthetic and native amyloid by colloidal gold immunoelectron microscopy. Amyloid fibrils isolated from tissue were insoluble on SDS-Polyacrylamide gels, and tended to aggregate while synthetic amyloid fibrils were completely solubilized, releasing only monomers of SP28 and SP17. Anti-SP28 immunostained cerebrovascular and plaque core amyloid, but not neurofibrillary tangles, in tissue section. Western blot analysis showed that anti-SP28 reacted with a 4 kDa band released from amyloid core-enriched preparations and leptomeninges. By contrast, a 16 kDa band corresponding to the tetramer of beta-protein was not recognized. These data suggest that as little as a 17 residue sequence of beta-protein may be required to form fibrils and that the complete sequence of the 4 kDa beta-protein may be important in determining insolubility and the formation of intermediate size polymers.

PubMed Disclaimer

Cited by

Reversible in vitro growth of Alzheimer disease beta-amyloid plaques by deposition of labeled amyloid peptide.
Maggio JE, Stimson ER, Ghilardi JR, Allen CJ, Dahl CE, Whitcomb DC, Vigna SR, Vinters HV, Labenski ME, Mantyh PW. Maggio JE, et al. Proc Natl Acad Sci U S A. 1992 Jun 15;89(12):5462-6. doi: 10.1073/pnas.89.12.5462. Proc Natl Acad Sci U S A. 1992. PMID: 1608956 Free PMC article.
Azo-dyes based small bifunctional molecules for metal chelation and controlling amyloid formation.
Rana M, Cho HJ, Roy TK, Mirica LM, Sharma AK. Rana M, et al. Inorganica Chim Acta. 2018 Feb 24;471:419-429. doi: 10.1016/j.ica.2017.11.029. Epub 2017 Nov 22. Inorganica Chim Acta. 2018. PMID: 30344337 Free PMC article.
Microanalysis of Alzheimer disease NFT and plaques.
Moretz RC, Iqbal K, Wisniewski HM. Moretz RC, et al. Environ Geochem Health. 1990 Mar;12(1-2):15-6. doi: 10.1007/BF01734044. Environ Geochem Health. 1990. PMID: 24202561
Synthetic peptides corresponding to different mutated regions of the amyloid gene in familial Creutzfeldt-Jakob disease show enhanced in vitro formation of morphologically different amyloid fibrils.
Goldfarb LG, Brown P, Haltia M, Ghiso J, Frangione B, Gajdusek DC. Goldfarb LG, et al. Proc Natl Acad Sci U S A. 1993 May 15;90(10):4451-4. doi: 10.1073/pnas.90.10.4451. Proc Natl Acad Sci U S A. 1993. PMID: 8506284 Free PMC article.
Synthetic peptide homologous to beta protein from Alzheimer disease forms amyloid-like fibrils in vitro.
Kirschner DA, Inouye H, Duffy LK, Sinclair A, Lind M, Selkoe DJ. Kirschner DA, et al. Proc Natl Acad Sci U S A. 1987 Oct;84(19):6953-7. doi: 10.1073/pnas.84.19.6953. Proc Natl Acad Sci U S A. 1987. PMID: 3477820 Free PMC article.

In vitro formation of amyloid fibrils from two synthetic peptides of different lengths homologous to Alzheimer's disease beta-protein - PubMed (original) (raw)